iPSC-based Drug Discovery and Development Team
Team Leader Haruhisa INOUE, M.D.,Ph.D.
Establish a platform for drug discovery using iPS cells
Ref:Inoue et al., The EMBO Journal,2014
Develop cellular-level disease phenotypes
We engage in the development of drug discovery researches using disease-specific iPS cells of RIKEN BRC cellbank at Keihanna in collaboration with the Cell Engineering Division,BRC,and CiRA,Kyoto University.